PT - JOURNAL ARTICLE AU - Amparo Güemes AU - Soumyajit Ray AU - Khaled Aboumerhi AU - Michael R. Desjardins AU - Anton Kvit AU - Anne E Corrigan AU - Brendan Fries AU - Timothy Shields AU - Robert D Stevens AU - Frank C Curriero AU - Ralph Etienne-Cummings TI - A Syndromic Surveillance Tool to Detect Anomalous Clusters of COVID-19 Symptoms in the United States AID - 10.1101/2020.08.18.20177295 DP - 2020 Jan 01 TA - medRxiv PG - 2020.08.18.20177295 4099 - http://medrxiv.org/content/early/2020/08/21/2020.08.18.20177295.short 4100 - http://medrxiv.org/content/early/2020/08/21/2020.08.18.20177295.full AB - Coronavirus SARS-COV-2 infections continue to spread across the world, yet effective large-scale disease detection and prediction remain limited. COVID Control: A Johns Hopkins University Study, is a novel syndromic surveillance approach, which collects body temperature and COVID-like illness (CLI) symptoms across the US using a smartphone app and applies spatio-temporal clustering techniques and cross-correlation analysis to create maps of abnormal symptomatology incidence that are made publicly available. The results of the cross-correlation analysis identify optimal temporal lags between symptoms and a range of COVID-19 outcomes, with new taste/smell loss showing the highest correlations. We also identified temporal clusters of change in taste/smell entries and confirmed COVID-19 incidence in Baltimore City and County. Further, we utilized an extended simulated dataset to showcase our analytics in Maryland. The resulting clusters can serve as indicators of emerging COVID-19 outbreaks, and support syndromic surveillance as an early warning system for disease prevention and control.Competing Interest StatementThe authors have declared no competing interest.Funding StatementNo external funding has been received for this study.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:COVID Control: A Johns Hopkins University Study was approved by the Johns Hopkins School of Public Health Institutional Review Board (IRB number IRB00012283). The study has been performed in accordance with the institutional guidelines and regulations. All participants have voluntarily agreed to be involved in the study by accepting an IRB approved informed consent form when installing the app.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe data may be available at the county level upon request.